Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis
Direct-to-Consumer Models for Prescription Drug Coverage: A New Trend in Coverage for GLP-1s The cost of GLP-1 medications to group health plans continues to increase rapidly as FDA approval expands and the percentage of participants and beneficiaries taking GLP-1 medications rises
The probiotic component contains two of the most clinically studied strains, LGG and BB-12, that show strong evidence for digestion and immune support, while the prebiotic portion is a non-fibrous blend that targets detrimental gut bacteria, like E
Ash manages the logistics, device integration, and data integrity behind the scenes so partners like Noom can focus on translating biomarker data into meaningful health change. As Nooms Chief Product Officer, Aaron Severs, noted, this model allows members to see their progress and adjust their plan as their needs evolve, making it "health you can see, wellbeing you can feel"
US$ 25.45
US$ 24.94
US$ 25.33
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
US$ 23.24
US$ 26.12
US$ 25.45
US$ 24.92
US$ 29.07
